Top Pharmaceuticals companies in South Korea by EBITDA

This ranking features the top 113 Pharmaceuticals companies in South Korea ranked by EBITDA, totalling a EBITDA of USD 21.61 B, for January 15, 2025.
#
Name
EBITDA
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 10.31 B
Dec. 31, 2023 USD 97.87 1.09%

South Korea

2
USD 5.45 B
Dec. 31, 2023 USD 166.75 2.20%

South Korea

3
USD 1.30 B
Dec. 31, 2023 USD 698.37 1.93%

South Korea

4
USD 720.20 M
Dec. 31, 2023 USD 125.83 1.12%

South Korea

5
USD 701.91 M
Dec. 31, 2023 USD 24.38 0.88%

South Korea

6
USD 341.62 M
Dec. 31, 2023 USD 42.83 0.90%

South Korea

7
USD 248.32 M
Dec. 31, 2023 USD 177.66 0.74%

South Korea

8
USD 220.89 M
Dec. 31, 2023 USD 64.45 0.31%

South Korea

9
USD 207.62 M
Dec. 31, 2023 USD 13.98 -3.04%

South Korea

10
USD 158.37 M
Dec. 31, 2023 USD 1.83 0.74%

South Korea

11
USD 151.57 M
Dec. 31, 2023 USD 28.71 -0.56%

South Korea

12
USD 134.99 M
Dec. 31, 2023 USD 104.35 -0.50%

South Korea

13
USD 130.41 M
Dec. 31, 2023 USD 38.94 0.04%

South Korea

14
USD 129.37 M
Dec. 31, 2023 USD 26.36 -7.63%

South Korea

15
USD 126.65 M
Dec. 31, 2023 USD 89.82 -0.84%

South Korea

16
USD 121.26 M
Dec. 31, 2023 USD 11.90 21.74%

South Korea

17
USD 108.57 M
Dec. 31, 2023 USD 68.20 0.14%

South Korea

18
USD 98.71 M
Dec. 31, 2023 USD 2.05 0.07%

South Korea

19
USD 97.87 M
Dec. 31, 2023 USD 89.21 -4.31%

South Korea

20
USD 88.33 M
Dec. 31, 2023 USD 171.86 2.57%

South Korea

21
USD 84.67 M
Dec. 31, 2023 USD 7.02 1.13%

South Korea

22
USD 84.33 M
Dec. 31, 2023 USD 108.37 -2.33%

South Korea

23
USD 68.52 M
Dec. 31, 2023 USD 16.03 -1.15%

South Korea

24
USD 68.11 M
Dec. 31, 2023 USD 10.59 -0.10%

South Korea

25
USD 64.41 M
Dec. 31, 2023 USD 13.23 1.89%

South Korea

26
USD 62.96 M
Dec. 31, 2023 USD 19.95 0.05%

South Korea

27
USD 59.16 M
Dec. 31, 2023 USD 9.53 1.69%

South Korea

28
USD 58.14 M
Dec. 31, 2023 USD 8.62 0.98%

South Korea

29
USD 56.08 M
Dec. 31, 2023 USD 10.34 -1.02%

South Korea

30
USD 51.79 M
Dec. 31, 2023 USD 3.84 0.74%

South Korea

31
USD 51.72 M
Dec. 31, 2023 USD 7.70 -1.01%

South Korea

32
USD 51.67 M
Dec. 31, 2023 USD 17.02 -2.20%

South Korea

33
USD 47.83 M
Dec. 31, 2023 USD 32.09 0.74%

South Korea

34
USD 41.64 M
Dec. 31, 2023 USD 38.12 0.02%

South Korea

35
USD 40.31 M
Dec. 31, 2023 USD 61.65 0.74%

South Korea

36
USD 39.04 M
Dec. 31, 2023 USD 7.40 0.83%

South Korea

37
USD 38.79 M
Dec. 31, 2023 USD 8.54 0.34%

South Korea

38
USD 38.25 M
Dec. 31, 2023 USD 26.87 -0.77%

South Korea

39
USD 37.75 M
Dec. 31, 2023 USD 4.13 2.75%

South Korea

40
USD 37.43 M
Dec. 31, 2023 USD 4.37 0.43%

South Korea

41
USD 37.05 M
Dec. 31, 2023 USD 5.78 -0.09%

South Korea

42
USD 36.48 M
Dec. 31, 2023 USD 10.03 -2.25%

South Korea

43
USD 35.83 M
Dec. 31, 2023 USD 36.83 -2.69%

South Korea

44
USD 34.66 M
Dec. 31, 2023 USD 26.12 -1.82%

South Korea

45
USD 33.99 M
Dec. 31, 2023 USD 16.27 0.32%

South Korea

46
USD 33.40 M
Dec. 31, 2023 USD 33.55 -1.07%

South Korea

47
USD 31.84 M
Dec. 31, 2023 USD 8.29 0.57%

South Korea

48
USD 30.92 M
Dec. 31, 2023 USD 53.54 0.36%

South Korea

49
USD 30.88 M
Dec. 31, 2023 USD 11.69 2.23%

South Korea

50
USD 28.11 M
Dec. 31, 2023 USD 11.90 0.22%

South Korea

Frequently Asked Questions
  • Which Pharmaceuticals company in South Korea has the highest EBITDA ?

    The Pharmaceuticals company in South Korea with the highest EBITDA is SK Inc. (KSE: 034730.KS) at USD 10.31 B.

  • Which Pharmaceuticals company in South Korea has the lowest EBITDA ?

    The Pharmaceuticals company in South Korea with the lowest EBITDA is SD BioSensor, Inc (KSE: 137310.KS) at USD -192.66 M.